Displaying all 2 publications

Abstract:
Sort:
  1. Fahmy O, El-Fayoumi AR, Gakis G, Amend B, Khairul-Asri MG, Stenzl A, et al.
    Cent European J Urol, 2015;68(4):466-70.
    PMID: 26855804 DOI: 10.5173/ceju.2015.627
    Laparoscopic pyeloplasty is considered a standard treatment for ureteropelvic junction obstruction (UPJO). However, the presence of another pathology makes it a more challenging operation and guides the surgeon towards open conversion. In this study, we present our experience in difficult pyeloplasty cases managed by laparoscopy.
  2. Khor V, Fahmy O, Lee CKS, Khairul-Asri MG
    Cent European J Urol, 2023;76(4):311-314.
    PMID: 38230320 DOI: 10.5173/ceju.2023.91
    Intravesical Bacillus Calmette-Guérin (BCG) therapy is a standard treatment for non-muscle invasive bladder cancer, but some patients experience side effects that lead to treatment discontinuation. Local side effects are typically mild, while systemic side effects can be severe and life-threatening. BCG therapy has immunotherapy effects on bladder cancer, but the mechanism is not fully understood. Due to its effect on the immune system, patients may also develop rare autoimmune complications, such as neuropathy. This case report suggests a potential association between BCG therapy and Guillain-Barré Syndrome (GBS), as a patient developed GBS after receiving intravesical BCG therapy for invasive bladder cancer.
Related Terms
Filters
Contact Us

Please provide feedback to Administrator (afdal@afpm.org.my)

External Links